Sporotrichosis

• CLINICAL_TRIALS research · 2025-08-13
  Clinical Trial Update: Antifungal Agents and Infrared Thermotherapy Alone or in Combination in the Treatment of Sporotrichosis [NA]

  This clinical trial investigates antifungal therapy with infrared thermotherapy, alone or in combination, for treating sporotrichosis, and i…

• FDA approval · 2025-03-12
  FDA Approved: ITRACONAZOLE — Supplemental Application (Ascend Laboratories, LLC)

  FDA approved a supplemental application for itraconazole from Ascend Laboratories, LLC, authorizing changes to the generic product under AND…

• FDA approval · 2025-01-29
  FDA Approved: ITRACONAZOLE — Supplemental Application (Camber Pharmaceuticals, Inc.)

  FDA approved a supplemental application for itraconazole by Camber Pharmaceuticals, expanding/updating labeling for the generic product.

• FDA approval · 2024-10-24
  FDA Approved: ITRACONAZOLE — Supplemental Application (Alembic Pharmaceuticals Inc.)

  FDA approved a supplemental application for itraconazole from Alembic Pharmaceuticals Inc., resulting in a label-related approval update for…

• CLINICAL_TRIALS trial_result · 2024-07-29
  Clinical Trial Update: A Study on Rare Dermatological Infections Conducted at Three Major Reference Hospitals in Costa Rica.

  A completed clinical trial conducted at three Costa Rican hospitals evaluating therapies for rare dermatological infections, including sporo…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2016-09-26
  FDA Approved: ITRACONAZOLE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approved Amneal Pharmaceuticals LLC's original application for itraconazole, granting a generic version of the antifungal medication. Th…

• FDA approval · 2015-10-30
  FDA Approved: ITRACONAZOLE — Original Application (Amneal Pharmaceuticals LLC)

  FDA approved Amneal Pharmaceuticals LLC's original ANDA for itraconazole, enabling a generic version of the antifungal agent to be marketed.

• CLINICAL_TRIALS trial_result · 2006-06-09
  Clinical Trial Update: Phase II Study of Fluconazole for Lymphocutaneous and Visceral Sporotrichosis [Phase 2]

  This completed Phase II trial evaluated fluconazole for lymphocutaneous and visceral sporotrichosis.

• CLINICAL_TRIALS trial_result · 2006-06-09
  Clinical Trial Update: Phase II Pilot Study of Fluconazole for Histoplasmosis, Blastomycosis, and Sporotrichosis [Phase 2]

  Phase II pilot study evaluating fluconazole for histoplasmosis, sporotrichosis, and blastomycosis has completed.

• CLINICAL_TRIALS trial_result · 2006-06-09
  Clinical Trial Update: Phase I/II Study of Itraconazole for Blastomycosis, Histoplasmosis, and Sporotrichosis [Phase 1, Phase 2]

  Phase I/II clinical trial update evaluating itraconazole for histoplasmosis, sporotrichosis, and blastomycosis; the study status is complete…